Guidelines Detail - NCCN
Archived NCCN Tumor Boards: Immune Checkpoint Inhibitors for First-Line Therapy in Esophagogastric/Esophagogastric Junction Cancer
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN …
The NCCN panel strongly recommends multidisciplinary team management as essential for all patients with esophageal or EGJ cancers. Best supportive care is an integral part of treatment, …
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN …
Multidisciplinary team management is essential for all patients with locally advanced esophageal or esophagogastric junction cancers. This selection from the NCCN Guidelines for Esophageal …
NCCN develops evidence-based cancer care recommendations used by health care providers worldwide. These frequently updated recommendations are the NCCN Clinical Practice …
2024年9月26日 · 2NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Esophageal Cancer. Version 4.2024 — July 30, 2024. Flatiron analysis of PD-L1 CPS and …
MRD番外篇丨基于ctDNA指导的MRD评估已写入结肠癌NCCN指南！
2021年2月23日 · 早期结肠癌（ESCC）是一种可治愈的恶性肿瘤，其定义为局限于肠道的肿瘤，有或没有局部区域淋巴结累及。 目前ESCC患者的治疗策略包括前期外科手术切除，然后对 …
NCCN Guidelines for Gastric and Esophageal Cancers Updates
2021年3月20日 · Key updates to the National Comprehensive Cancer Network (NCCN) guidelines for gastric and esophageal cancers include the incorporation of immune checkpoint inhibitors …
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN …
2023年4月1日 · Both the National Comprehensive Cancer Network (NCCN) (14) and the CSCO recommend neoadjuvant chemoradiotherapy (nCRT) as a standard neoadjuvant treatment …
Real-World Treatment Patterns and Outcomes in Patients …
The NCCN Guidelines ® have added the programmed death 1 (PD‐1) inhibitor pembrolizumab as a recommended 2L therapy option (category 1) for patients with ESCC tumors that express …
食管鳞状细胞癌筛查 5 大要点 - 丁香园
2018年10月22日 · ESCC 筛查的主要目的在于检测出无症状的食管鳞状异型增生和早期 ESCC，以便进行治愈性治疗。 一些研究表明，对高危人群实施内镜筛查计划，可提高早期检 …